Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy Volunteers
Authors:
Open Access
- 12 August 2009
- journal article
- conference paper
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 55 (6) , 1627-1636
Abstract
Gastric acid plays an important role in the pathogenesis of gastric mucosal lesions. We investigated whether aspirin-induced gastric mucosal injury might have any association with the intragastric pH. Fifteen healthy, Helicobacter pylori-negative volunteers randomly underwent the four different 7-day regimens: (1) aspirin 100 mg, (2) rabeprazole 10 mg, (3) aspirin 100 mg + rabeprazole 10 mg, and (4) aspirin 100 mg + rabeprazole 40 mg. Gastric mucosal injury based on the modified Lanza score (MLS), 24-h intragastric pH, and histopathology of gastric mucosa were evaluated prior to the start and on day 7 of each regimen. The median MLSs were 0 in the baseline and the rabeprazole 10 mg regimen. The median MLS in the aspirin regimen was 3, while those in both aspirin + rabeprazole 10 mg and aspirin + rabeprazole 40 mg regimens were 0. Rabeprazole significantly prevented the gastric mucosal injury by aspirin (P = 0.001 for rabeprazole 10 mg and P = 0.005 for rabeprazole 40 mg). The MLSs were negatively correlated with the 24-h intragastric pH (P = −0.711, < 0.001), whereas aspirin had no effect on the intragastric pH. Aspirin expanded the mean diameter of the microvessels of the gastric mucosa, which, in turn, was negatively correlated with the intragastric pH. Aspirin might induce gastric mucosal injury by affecting the mucosal microvessels in an acid-dependent manner. Sustained maintenance of the intragastric pH at an elevated value is necessary to prevent gastric mucosal damage induced by aspirin.Keywords
This publication has 32 references indexed in Scilit:
- Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated ratsEuropean Journal of Pharmacology, 2007
- Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinAlimentary Pharmacology & Therapeutics, 2005
- Upper gastrointestinal haemorrhage associated with low‐dose aspirin and anti‐thrombotic drugs – a 6‐year analysis and comparison with non‐steroidal anti‐inflammatory drugsAlimentary Pharmacology & Therapeutics, 2005
- Proton‐pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non‐steroidal anti‐inflammatory drugsAlimentary Pharmacology & Therapeutics, 2004
- Pharmacogenomics of proton pump inhibitorsPharmacogenomics, 2004
- Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- INDOMETHACIN DAMAGE TO RAT GASTRIC MUCOSA IS MARKEDLY DEPENDENT ON LUMINAL pHClinical and Experimental Pharmacology and Physiology, 1996
- Effects of indomethacin on intragastric pH and meal‐stimulated serum gastrin secretion in rheumatoid arthritis patientsAlimentary Pharmacology & Therapeutics, 1993
- Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damageThe American Journal of Medicine, 1989
- Mechanisms of Gastrointestinal Toxicity of NSAIDsScandinavian Journal of Rheumatology, 1988